Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of E1K After Single Dose in Patients With Knee Osteoarthritis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of pain relief treatment
on knee osteoarthritis when administered E1K or placebo in patients with knee osteoarthritis
aged 40 to 70 to determine the optimal dose.